|
21TP
Open-state structure of veratridine-activated human Nav1.7
Deposited 2025-12-24
|
Different construct
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
20–192(173 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6
Y01 CHOLESTEROL HEMISUCCINATE × 4
LPE 1-O-OCTADECYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 8
PCW 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 2
A1E26 Veratridine × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.00 Å
|
|
21TQ
The structure of Nav1.7 with veratridine standing near the IFM motif (site I)
Deposited 2025-12-24
|
Different construct
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
20–192(173 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6
LPE 1-O-OCTADECYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 8
A1E26 Veratridine × 1
Y01 CHOLESTEROL HEMISUCCINATE × 4
PCW 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 2
P3X (5E,17R,20S)-23-amino-20-hydroxy-14,20-dioxo-15,19,21-trioxa-20lambda~5~-phosphatricos-5-en-17-yl hexadecanoate × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.70 Å
|
|
25IH
Cryo-EM structure of human Nav1.6 in complex with Cn2
Deposited 2026-04-06
|
Different oligomeric state
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
1–218(218 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6
9Z9 (3beta,14beta,17beta,25R)-3-[4-methoxy-3-(methoxymethyl)butoxy]spirost-5-en × 1
PCW 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 5
Y01 CHOLESTEROL HEMISUCCINATE × 3
CLR CHOLESTEROL × 1
P5S O-[(R)-{[(2R)-2,3-bis(octadecanoyloxy)propyl]oxy}(hydroxy)phosphoryl]-L-serine × 1
LPE 1-O-OCTADECYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 1
P3X (5E,17R,20S)-23-amino-20-hydroxy-14,20-dioxo-15,19,21-trioxa-20lambda~5~-phosphatricos-5-en-17-yl hexadecanoate × 1
PT5 [(2R)-1-octadecanoyloxy-3-[oxidanyl-[(1R,2R,3S,4R,5R,6S)-2,3,6-tris(oxidanyl)-4,5-diphosphonooxy-cyclohexyl]oxy-phospho ryl]oxy-propan-2-yl] (8Z)-icosa-5,8,11,14-tetraenoate × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.80 Å
|
|
25IJ
Cryo-EM structure of human Nav1.6 in complex with delta-paraponeritoxin-Pc1a
Deposited 2026-04-06
|
Different construct
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
20–192(173 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 4
9Z9 (3beta,14beta,17beta,25R)-3-[4-methoxy-3-(methoxymethyl)butoxy]spirost-5-en × 1
PCW 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 3
Y01 CHOLESTEROL HEMISUCCINATE × 2
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.10 Å
|
|
6AGF
Structure of the human voltage-gated sodium channel Nav1.4 in complex with beta1
Deposited 2018-08-11
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
1–218(218 aa)
|
Not recorded
|
6OU [(2~{R})-1-[2-azanylethoxy(oxidanyl)phosphoryl]oxy-3-hexadecanoyloxy-propan-2-yl] (~{Z})-octadec-9-enoate × 6
9Z9 (3beta,14beta,17beta,25R)-3-[4-methoxy-3-(methoxymethyl)butoxy]spirost-5-en × 1
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 5.9
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.20 Å
|
|
6J8G
Structure of human voltage-gated sodium channel Nav1.7 in complex with auxiliary beta subunits, huwentoxin-IV and saxitoxin (Y1755 up)
Deposited 2019-01-19
|
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
1–218(218 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 7
9SL [(3aS,4R,10aS)-2,6-diamino-10,10-dihydroxy-3a,4,9,10-tetrahydro-3H,8H-pyrrolo[1,2-c]purin-4-yl]methyl carbamate × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.20 Å
|
|
6J8H
Structure of human voltage-gated sodium channel Nav1.7 in complex with auxiliary beta subunits, huwentoxin-IV and saxitoxin (Y1755 down)
Deposited 2019-01-19
|
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
1–218(218 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 7
9SL [(3aS,4R,10aS)-2,6-diamino-10,10-dihydroxy-3a,4,9,10-tetrahydro-3H,8H-pyrrolo[1,2-c]purin-4-yl]methyl carbamate × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.20 Å
|
|
6J8I
Structure of human voltage-gated sodium channel Nav1.7 in complex with auxiliary beta subunits, ProTx-II and tetrodotoxin (Y1755 up)
Deposited 2019-01-19
|
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
1–218(218 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 7
9SR (1R,5R,6R,7R,9S,11S,12S,13S,14S)-3-amino-14-(hydroxymethyl)-8,10-dioxa-2,4-diazatetracyclo[7.3.1.1~7,11~.0~1,6~]tetradec-3-ene-5,9,12,13,14-pentol (non-preferred name) × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.20 Å
|
|
6J8J
Structure of human voltage-gated sodium channel Nav1.7 in complex with auxiliary beta subunits, ProTx-II and tetrodotoxin (Y1755 down)
Deposited 2019-01-19
|
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
1–218(218 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 7
9SR (1R,5R,6R,7R,9S,11S,12S,13S,14S)-3-amino-14-(hydroxymethyl)-8,10-dioxa-2,4-diazatetracyclo[7.3.1.1~7,11~.0~1,6~]tetradec-3-ene-5,9,12,13,14-pentol (non-preferred name) × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.20 Å
|
|
7W77
cryo-EM structure of human NaV1.3/beta1/beta2-bulleyaconitineA
Deposited 2021-12-03
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
1–218(218 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5
9Z9 (3beta,14beta,17beta,25R)-3-[4-methoxy-3-(methoxymethyl)butoxy]spirost-5-en × 3
6OU [(2~{R})-1-[2-azanylethoxy(oxidanyl)phosphoryl]oxy-3-hexadecanoyloxy-propan-2-yl] (~{Z})-octadec-9-enoate × 16
966 [(1S,2R,3R,4R,5R,6S,8R,9S,13S,16S,17R,18R)-11-ethyl-5-hydroxy-6,16,18-trimethoxy-4-(4-methoxybenzoyl)-13-(methoxymethyl)-11-azahexacyclo[7.7.2.12,5.01,10.03,8.013,17]nonadecan-8-yl] acetate × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.30 Å
|
|
7W7F
Cryo-EM structure of human NaV1.3/beta1/beta2-ICA121431
Deposited 2021-12-04
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
1–218(218 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5
6OU [(2~{R})-1-[2-azanylethoxy(oxidanyl)phosphoryl]oxy-3-hexadecanoyloxy-propan-2-yl] (~{Z})-octadec-9-enoate × 17
8DE 2,2-diphenyl-~{N}-[4-(1,3-thiazol-2-ylsulfamoyl)phenyl]ethanamide × 1
9Z9 (3beta,14beta,17beta,25R)-3-[4-methoxy-3-(methoxymethyl)butoxy]spirost-5-en × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.35 Å
|
|
7W9K
Cryo-EM structure of human Nav1.7-beta1-beta2 complex at 2.2 angstrom resolution
Deposited 2021-12-09
|
Different oligomeric state
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
1–218(218 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5
P5S O-[(R)-{[(2R)-2,3-bis(octadecanoyloxy)propyl]oxy}(hydroxy)phosphoryl]-L-serine × 3
Y01 CHOLESTEROL HEMISUCCINATE × 6
9Z9 (3beta,14beta,17beta,25R)-3-[4-methoxy-3-(methoxymethyl)butoxy]spirost-5-en × 1
NA SODIUM ION × 1
LPE 1-O-OCTADECYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 15
1PW (2S,3R,4E)-2-(acetylamino)-3-hydroxyoctadec-4-en-1-yl dihydrogen phosphate × 1
PCW 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 5
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.20 Å
|
|
7W9L
Cryo-EM structure of human Nav1.7(E406K)-beta1-beta2 complex
Deposited 2021-12-10
|
Different oligomeric state
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
1–218(218 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5
P5S O-[(R)-{[(2R)-2,3-bis(octadecanoyloxy)propyl]oxy}(hydroxy)phosphoryl]-L-serine × 3
Y01 CHOLESTEROL HEMISUCCINATE × 6
9Z9 (3beta,14beta,17beta,25R)-3-[4-methoxy-3-(methoxymethyl)butoxy]spirost-5-en × 1
LPE 1-O-OCTADECYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 14
PCW 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 5
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.50 Å
|
|
7W9M
Cryo-EM structure of human Nav1.7(E406K) in complex with auxiliary beta subunits, ProTx-II and tetrodotoxin (S6IV pi helix conformer)
Deposited 2021-12-10
|
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
1–218(218 aa)
|
Not recorded
|
9SR (1R,5R,6R,7R,9S,11S,12S,13S,14S)-3-amino-14-(hydroxymethyl)-8,10-dioxa-2,4-diazatetracyclo[7.3.1.1~7,11~.0~1,6~]tetradec-3-ene-5,9,12,13,14-pentol (non-preferred name) × 1
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6
P5S O-[(R)-{[(2R)-2,3-bis(octadecanoyloxy)propyl]oxy}(hydroxy)phosphoryl]-L-serine × 1
Y01 CHOLESTEROL HEMISUCCINATE × 5
LPE 1-O-OCTADECYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.00 Å
|
|
7W9P
Cryo-EM structure of human Nav1.7(E406K) in complex with auxiliary beta subunits, huwentoxin-IV and saxitoxin (S6IV pi helix conformer)
Deposited 2021-12-10
|
Different oligomeric state
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
1–218(218 aa)
|
Not recorded
|
9SL [(3aS,4R,10aS)-2,6-diamino-10,10-dihydroxy-3a,4,9,10-tetrahydro-3H,8H-pyrrolo[1,2-c]purin-4-yl]methyl carbamate × 1
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5
P5S O-[(R)-{[(2R)-2,3-bis(octadecanoyloxy)propyl]oxy}(hydroxy)phosphoryl]-L-serine × 3
Y01 CHOLESTEROL HEMISUCCINATE × 6
LPE 1-O-OCTADECYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 13
1PW (2S,3R,4E)-2-(acetylamino)-3-hydroxyoctadec-4-en-1-yl dihydrogen phosphate × 1
PCW 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 5
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.90 Å
|
|
7W9T
Cryo-EM structure of human Nav1.7(E406K) in complex with auxiliary beta subunits, huwentoxin-IV and saxitoxin (S6IV alpha helix conformer)
Deposited 2021-12-10
|
Different oligomeric state
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
1–218(218 aa)
|
Not recorded
|
9SL [(3aS,4R,10aS)-2,6-diamino-10,10-dihydroxy-3a,4,9,10-tetrahydro-3H,8H-pyrrolo[1,2-c]purin-4-yl]methyl carbamate × 1
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5
P5S O-[(R)-{[(2R)-2,3-bis(octadecanoyloxy)propyl]oxy}(hydroxy)phosphoryl]-L-serine × 2
Y01 CHOLESTEROL HEMISUCCINATE × 5
9Z9 (3beta,14beta,17beta,25R)-3-[4-methoxy-3-(methoxymethyl)butoxy]spirost-5-en × 1
LPE 1-O-OCTADECYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 14
PCW 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 5
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.00 Å
|
|
7XM9
Cryo-EM structure of human NaV1.7/beta1/beta2-XEN907
Deposited 2022-04-25
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
1–218(218 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5
G2E (7~{R})-1'-pentylspiro[6~{H}-furo[3,2-f][1,3]benzodioxole-7,3'-indole]-2'-one × 1
6OU [(2~{R})-1-[2-azanylethoxy(oxidanyl)phosphoryl]oxy-3-hexadecanoyloxy-propan-2-yl] (~{Z})-octadec-9-enoate × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.22 Å
|
|
7XMF
Cryo-EM structure of human NaV1.7/beta1/beta2-Nav1.7-IN2
Deposited 2022-04-25
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
1–218(218 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6
G2W 3-[[4-[3-(4-fluoranyl-2-methyl-phenoxy)azetidin-1-yl]pyrimidin-2-yl]amino]-~{N}-methyl-benzamide × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.07 Å
|
|
7XMG
Cryo-EM structure of human NaV1.7/beta1/beta2-TCN-1752
Deposited 2022-04-25
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
1–218(218 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5
G4I (1~{Z})-~{N}-[2-methyl-3-[(~{E})-[6-[4-[[4-(trifluoromethyloxy)phenyl]methoxy]piperidin-1-yl]-1~{H}-1,3,5-triazin-2-ylidene]amino]phenyl]ethanimidic acid × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.09 Å
|
|
7XVE
Human Nav1.7 mutant class-I
Deposited 2022-05-21
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
1–218(218 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 7
Y01 CHOLESTEROL HEMISUCCINATE × 1
CLR CHOLESTEROL × 4
LPE 1-O-OCTADECYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 18
1PW (2S,3R,4E)-2-(acetylamino)-3-hydroxyoctadec-4-en-1-yl dihydrogen phosphate × 1
PCW 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 6
P5S O-[(R)-{[(2R)-2,3-bis(octadecanoyloxy)propyl]oxy}(hydroxy)phosphoryl]-L-serine × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.70 Å
|
|
7XVF
Nav1.7 mutant class2
Deposited 2022-05-22
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
1–218(218 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 7
Y01 CHOLESTEROL HEMISUCCINATE × 5
CLR CHOLESTEROL × 1
LPE 1-O-OCTADECYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 17
1PW (2S,3R,4E)-2-(acetylamino)-3-hydroxyoctadec-4-en-1-yl dihydrogen phosphate × 1
PCW 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 6
P5S O-[(R)-{[(2R)-2,3-bis(octadecanoyloxy)propyl]oxy}(hydroxy)phosphoryl]-L-serine × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.80 Å
|
|
8FHD
Cryo-EM structure of human voltage-gated sodium channel Nav1.6
Deposited 2022-12-14
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
1–218(218 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 7
Y01 CHOLESTEROL HEMISUCCINATE × 4
CLR CHOLESTEROL × 1
LPE 1-O-OCTADECYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 5
PCW 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 3
P5S O-[(R)-{[(2R)-2,3-bis(octadecanoyloxy)propyl]oxy}(hydroxy)phosphoryl]-L-serine × 2
9Z9 (3beta,14beta,17beta,25R)-3-[4-methoxy-3-(methoxymethyl)butoxy]spirost-5-en × 1
P3X (5E,17R,20S)-23-amino-20-hydroxy-14,20-dioxo-15,19,21-trioxa-20lambda~5~-phosphatricos-5-en-17-yl hexadecanoate × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5;25 mM Tris-HCl (pH 7.5), 150 mM NaCl and 0.02% GDN
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.10 Å
|
|
8G1A
Cryo-EM structure of Nav1.7 with CBD
Deposited 2023-02-01
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
1–218(218 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6
P0T cannabidiol × 2
P5S O-[(R)-{[(2R)-2,3-bis(octadecanoyloxy)propyl]oxy}(hydroxy)phosphoryl]-L-serine × 2
Y01 CHOLESTEROL HEMISUCCINATE × 5
9Z9 (3beta,14beta,17beta,25R)-3-[4-methoxy-3-(methoxymethyl)butoxy]spirost-5-en × 1
LPE 1-O-OCTADECYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 13
PCW 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 4
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.80 Å
|
|
8GZ1
Cryo-EM structure of human NaV1.6/beta1/beta2,apo state
Deposited 2022-09-24
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain D
1–218(218 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2
NA SODIUM ION × 2
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.40 Å
|
|
8GZ2
Cryo-EM structure of human NaV1.6/beta1/beta2-4,9-anhydro-tetrodotoxin
Deposited 2022-09-24
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain D
1–218(218 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2
WMK (1R,2S,3S,4R,5R,9S,11S,12S,14R)-7-amino-2,4,12-trihydroxy-2-(hydroxymethyl)-10,13,15-trioxa-6,8-diazapentacyclo[7.4.1.1~3,12~.0~5,11~.0~5,14~]pentadec-7-en-8-ium (non-preferred name) × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.30 Å
|
|
8I5B
Structure of human Nav1.7 in complex with bupivacaine
Deposited 2023-01-24
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
1–218(218 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 7
P5S O-[(R)-{[(2R)-2,3-bis(octadecanoyloxy)propyl]oxy}(hydroxy)phosphoryl]-L-serine × 1
Y01 CHOLESTEROL HEMISUCCINATE × 6
LPE 1-O-OCTADECYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 6
PCW 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 5
OJ0 Levobupivacaine × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.70 Å
|
|
8I5G
Structure of human Nav1.7 in complex with PF-05089771
Deposited 2023-01-25
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
1–192(192 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5
Y01 CHOLESTEROL HEMISUCCINATE × 2
9Z9 (3beta,14beta,17beta,25R)-3-[4-methoxy-3-(methoxymethyl)butoxy]spirost-5-en × 1
T70 PF-05089771 × 1
NA SODIUM ION × 1
LPE 1-O-OCTADECYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 8
PCW 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 5
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.70 Å
|
|
8I5X
Structure of human Nav1.7 in complex with Vinpocetine
Deposited 2023-01-26
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
1–218(218 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5
P5S O-[(R)-{[(2R)-2,3-bis(octadecanoyloxy)propyl]oxy}(hydroxy)phosphoryl]-L-serine × 1
Y01 CHOLESTEROL HEMISUCCINATE × 5
9Z9 (3beta,14beta,17beta,25R)-3-[4-methoxy-3-(methoxymethyl)butoxy]spirost-5-en × 1
T7F Vinpocetine × 1
LPE 1-O-OCTADECYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 11
PCW 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 5
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.90 Å
|
|
8I5Y
Structure of human Nav1.7 in complex with vixotrigine
Deposited 2023-01-26
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
1–218(218 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5
P5S O-[(R)-{[(2R)-2,3-bis(octadecanoyloxy)propyl]oxy}(hydroxy)phosphoryl]-L-serine × 1
Y01 CHOLESTEROL HEMISUCCINATE × 4
9Z9 (3beta,14beta,17beta,25R)-3-[4-methoxy-3-(methoxymethyl)butoxy]spirost-5-en × 1
TB4 Vixotrigine × 1
NA SODIUM ION × 1
LPE 1-O-OCTADECYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 14
1PW (2S,3R,4E)-2-(acetylamino)-3-hydroxyoctadec-4-en-1-yl dihydrogen phosphate × 1
PCW 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 5
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.60 Å
|
|
8J4F
Structure of human Nav1.7 in complex with Hardwickii acid
Deposited 2023-04-19
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
1–218(218 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5
UK0 (4~{a}~{R},5~{S},6~{R},8~{a}~{R})-5-[2-(furan-3-yl)ethyl]-5,6,8~{a}-trimethyl-3,4,4~{a},6,7,8-hexahydronaphthalene-1-carboxylic acid × 1
Y01 CHOLESTEROL HEMISUCCINATE × 3
9Z9 (3beta,14beta,17beta,25R)-3-[4-methoxy-3-(methoxymethyl)butoxy]spirost-5-en × 1
LPE 1-O-OCTADECYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 10
PCW 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 4
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.00 Å
|
|
8S9B
Cryo-EM structure of Nav1.7 with LCM
Deposited 2023-03-27
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
1–218(218 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 4
LQO lacosamide × 2
P5S O-[(R)-{[(2R)-2,3-bis(octadecanoyloxy)propyl]oxy}(hydroxy)phosphoryl]-L-serine × 2
Y01 CHOLESTEROL HEMISUCCINATE × 4
LPE 1-O-OCTADECYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 8
PCW 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 3
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.90 Å
|
|
8S9C
Cryo-EM structure of Nav1.7 with CBZ
Deposited 2023-03-27
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
1–218(218 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5
N6W benzo[b][1]benzazepine-11-carboxamide × 1
P5S O-[(R)-{[(2R)-2,3-bis(octadecanoyloxy)propyl]oxy}(hydroxy)phosphoryl]-L-serine × 3
Y01 CHOLESTEROL HEMISUCCINATE × 5
LPE 1-O-OCTADECYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 9
PCW 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 4
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.20 Å
|
|
8THG
Cryo-EM structure of Nav1.7 with RLZ
Deposited 2023-07-16
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
1–218(218 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5
657 6-(trifluoromethoxy)-1,3-benzothiazol-2-amine × 1
Y01 CHOLESTEROL HEMISUCCINATE × 3
LPE 1-O-OCTADECYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 6
PCW 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 1
P5S O-[(R)-{[(2R)-2,3-bis(octadecanoyloxy)propyl]oxy}(hydroxy)phosphoryl]-L-serine × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.90 Å
|
|
8THH
Cryo-EM structure of Nav1.7 with LTG
Deposited 2023-07-16
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
1–218(218 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5
IYJ (6M)-6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine × 2
Y01 CHOLESTEROL HEMISUCCINATE × 4
LPE 1-O-OCTADECYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 6
PCW 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 3
P5S O-[(R)-{[(2R)-2,3-bis(octadecanoyloxy)propyl]oxy}(hydroxy)phosphoryl]-L-serine × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.70 Å
|
|
8XMM
Voltage-gated sodium channel Nav1.7 variant M9
Deposited 2023-12-27
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
1–218(218 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6
CLR CHOLESTEROL × 1
LPE 1-O-OCTADECYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 9
1PW (2S,3R,4E)-2-(acetylamino)-3-hydroxyoctadec-4-en-1-yl dihydrogen phosphate × 1
PCW 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 6
P5S O-[(R)-{[(2R)-2,3-bis(octadecanoyloxy)propyl]oxy}(hydroxy)phosphoryl]-L-serine × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.89 Å
|
|
8XMN
Voltage-gated sodium channel Nav1.7 variant M2
Deposited 2023-12-27
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
1–218(218 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6
LPE 1-O-OCTADECYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 5
PCW 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 3
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.37 Å
|
|
8XMO
Voltage-gated sodium channel Nav1.7 variant M4
Deposited 2023-12-27
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
1–218(218 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6
LPE 1-O-OCTADECYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 7
PCW 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 5
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.39 Å
|
|
9DK5
Cryo-EM structure of human Nav1.6 in complex with PaurTx3
Deposited 2024-09-08
|
Different oligomeric state
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain C
1–218(218 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 7
Y01 CHOLESTEROL HEMISUCCINATE × 3
PCW 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 4
CLR CHOLESTEROL × 1
P5S O-[(R)-{[(2R)-2,3-bis(octadecanoyloxy)propyl]oxy}(hydroxy)phosphoryl]-L-serine × 1
LPE 1-O-OCTADECYL-SN-GLYCERO-3-PHOSPHOCHOLINE × 1
9Z9 (3beta,14beta,17beta,25R)-3-[4-methoxy-3-(methoxymethyl)butoxy]spirost-5-en × 1
P3X (5E,17R,20S)-23-amino-20-hydroxy-14,20-dioxo-15,19,21-trioxa-20lambda~5~-phosphatricos-5-en-17-yl hexadecanoate × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.90 Å
|